investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Simon D Spivack

Exhaled microRNAs leveraged for lung cancer risk assessment

Trachea, bronchus and lung

Alexander D Sorkin

Pathogenesis of Cancer: Role of EGF Receptor Endocytosis

Trachea, bronchus and lung

Pathology

Giovanna Tosato

A Role for KSHV in the Pathogenesis of Malignancies

Trachea, bronchus and lung

Pathology Hematology and hematologic malignancies

Eric Alejandro Sweet-Cordero

Novel effectors of Kras in oncogenesis, senescence and tumor progression

Trachea, bronchus and lung

Peter S Hammerman

Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers

Trachea, bronchus and lung

Stefan Posse

Early Detection of Response to Treatment in Cancer by Hyperpolarized Metabolic MR

Trachea, bronchus and lung

Pathology

Kim O'Neill

Cancer Immunology Research at Brigham Young University

Trachea, bronchus and lung

Sandy A. Napel

Tools for Linking and Mining image and Genomic Data in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Curtis Harris

p53, Aging, and Cancer

Trachea, bronchus and lung